期刊文献+

DNA含量和倍体类型与食管鳞状细胞癌淋巴结转移的关系

Correlation of DNA content, DNA ploidy status and lymph node metastasis of esophageal squamous cellcarcinoma
下载PDF
导出
摘要 目的探讨DNA含量和倍体类型与食管鳞状细胞癌淋巴结转移的关系。方法采用流式细胞技术对手术切除的167例食管鳞癌患者新鲜标本进行DNA分析,计算DNA指数并判断倍体类型,分析DNA含量和倍体类型与食管鳞癌淋巴结转移情况的关系。结果①食管鳞癌患者异倍体出现率为81.44%,食管鳞癌在早期就已出现了DNA含量和倍体类型的改变;②有淋巴结转移组食管鳞癌DNA含量明显高于无淋巴结转移组食管鳞癌(t=2.53;P=0.012);③异倍体食管鳞癌淋巴结转移率和淋巴结转移度明显高于二倍体(χ2=4.06;P=0.044和χ2=7.23;P=0.007),且早期即可出现淋巴结转移。结论 DNA含量高的食管鳞癌和异倍体食管鳞癌更容易发生淋巴结。 Objective To investigate the correlation of DNA content, DNA ploidy status and lymph node metastasis of esophageal squamous cell carcinoma(ESCC). Methods DNA analysis was carried out respectively by flow cytometry in the specimens from 167 patients with resectable ESCC. DNA index (DI) and ploidy status was measured respectively. Then analyze the correlation of DI and DNA ploidy status with lymph node metastasis of ESCC. Results ①Heteroploidy rate in ESCC was 81.44%. Even in early stage of ESCC, the diversity of DNA index and ploidy status could be detected; ②DNA index was higher in group with lymph node metastasis than that without lymph node metastasis;③Comparing with ESCC with DNA diploidy, ESCC with DNA heteroploidy showed higher lymph nodes metastasis rate and lymph node metastasis ratio. Lymph node metastasis occurred even in early stage of ESCC with DNA heteroploidy. Conclusion Esophageal squamous cell carcinoma with higher DNA content or DNA heteroploidy more likely metastasizes to lymph node.
出处 《中国现代药物应用》 2014年第6期3-4,共2页 Chinese Journal of Modern Drug Application
关键词 食管 肿瘤 淋巴结 DNA含量 DNA倍体 Esophagus Neoplasm Lymph node DNA content DNA ploidy
  • 相关文献

参考文献7

二级参考文献46

  • 1孙小蓉,李玉兰,车东媛,晏想成,凌慧芳,凃洪章,汪键.用细胞DNA定量分析方法进行宫颈癌普查的临床研究[J].诊断病理学杂志,2005,12(1):12-16. 被引量:67
  • 2刘进康,曾纪珍,周建华.周围型肺腺、鳞癌CT征象与癌细胞核DNA含量关系的研究[J].中华放射学杂志,1996,30(1):15-19. 被引量:55
  • 3左连富 刘洪祥 等.流式细胞术检测石蜡包埋肿瘤细胞DNA含量的样品制备方法[J].中华病理学杂志,1988,17:23-23. 被引量:13
  • 4吴云飞,陈峻青,何三光,马东初.胃癌细胞DNA含量、细胞增殖比率与淋巴结转移规律的研究[J].中华肿瘤杂志,1997,19(1):62-64. 被引量:19
  • 5Barlogie B, Raber MN, Schumarm J, et al. Flow cytometry in clinic cancer research. Cancer Res, 1983,43:3982-3997. 被引量:1
  • 6Dyszkiewicz W, Kasprzyk M, Piwkowski C, et al. The prognostic value of DNA content analysis in patients with squamous cell lung Cancer treated surgicallv, Lung Cancer, 2000,29: 161-167. 被引量:1
  • 7Costa A, Silvestrini R, Mochen C, et al. p53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung.cancer. Br J Cancer, 1996,73:914-919. 被引量:1
  • 8lsobe H, Miyamoto H, Shimizu T, et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer, 1990,65: 1391-1395. 被引量:1
  • 9Dyszkiewicz W, Kasprzyk M, Piwkowski C, et al. Prognostic significance of DNA ploidy in squamous cell lung carcinoma: is it really worth it? Ann Thorac Surg , 2000,70:1629-1633. 被引量:1
  • 10Jeanfaivre T, Chassevent A, Geslin J, et al. Prognostic value of flow cytometry in squamous cell bronchogenic cancer: a retrospective study of 61 cases. Bull Cancer, 1997,84:597-602. 被引量:1

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部